NSC population and proliferation decrease drastically during the second postnatal week of DG development. حسب Cristina Medina-Menéndez (21800157)

Comparison of diffusion simulations: implicit scheme of the GDE with a 30-second time step (blue line), implicit scheme of the PNGM with α = 0.6 and a 15-second time step (green li... حسب Mouad Klai (20818364)

الموضوعات:

Disturbance of coherent behaviour leads to a decrease in information transfer. حسب Hannah Zoller (19688084)

Naringenin decreases total cell viability. حسب Lauren A. Eanes (20995499)

<b>Supporting data for manuscript</b> "<b>Voluntary locomotion induces an early and remote hemodynamic decrease in the large cerebral veins</b>" حسب Kira Shaw (18796168)

"…<p dir="ltr">The CSV file 'Eyreetal_DrainingVein_SourceData' contains the averaged time series traces and extracted metrics from individual experiments used across Figures 1-5 in the manuscript "Voluntary locomotion induces an early and remote hemodynamic decrease in the large cerebral veins". …"

Comparison of diffusion simulation using the implicit and explicit schemes of the graph diffusion equation: the implicit scheme time step was set to 30 seconds, while the explicit... حسب Mouad Klai (20818364)

الموضوعات:

Mean and standard error of sensory properties. حسب Tomoe Hayakawa (20978784)

الموضوعات:

Mean and standard error of pupil diameter in the dim states. حسب Tomoe Hayakawa (20978784)

الموضوعات:

Repetitive stress induces a decrease in sound-evoked activity. حسب Ghattas Bisharat (20706928)

"…<p>(a) Left: noise-evoked activity rates at different noise intensities for chronically tracked PPys cells in baseline and repeated stress conditions (<i>N</i> = 5 mice, <i>n</i> = 285 neurons, mean ± SE). …"

Frequency Chart for optimal maxima case (Frequency = 1.714) (a), second optimal maxima case (Frequency = 1.692) (b), optimal minima case (Frequency = 0.946) (c) and second optimal... حسب Muhammad Hammad Bucha (21736111)

الموضوعات:

Screening for gHgLgO interaction partners reveals decreased binding of the gO249 mutant to cell surfaces. حسب Lena Thiessen (17605194)

Antibody and antigen responses to Lufotrelvir vs placebo day 1–90. حسب Elizabeth S. Munroe (21568166)

الموضوعات:

Antibody and antigen responses to nMAb vs placebo day 1–90 for Sotrovimab. حسب Elizabeth S. Munroe (21568166)

الموضوعات:

Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab. حسب Elizabeth S. Munroe (21568166)

الموضوعات:

Antibody and antigen responses to Ensovibep vs placebo day 1–90. حسب Elizabeth S. Munroe (21568166)

الموضوعات:

Long-term anti-nucleocapsid response by baseline patient characteristics. حسب Elizabeth S. Munroe (21568166)

الموضوعات:

Antibody and antigen responses by baseline anti-spike neutralizing response assay positivity. حسب Elizabeth S. Munroe (21568166)

الموضوعات:

Baseline patient characteristics across neutralizing monoclonal antibody trials. حسب Elizabeth S. Munroe (21568166)

الموضوعات:

Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for neutralizing monoclonal antibodies, among patients alive and with day 90 antibody and antigen measu... حسب Elizabeth S. Munroe (21568166)

الموضوعات:

Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for nMAbs, among patients alive and with day 90 antibody and antigen measures (Sensitivity Analysis). حسب Elizabeth S. Munroe (21568166)

الموضوعات: